MedPath

Alio, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Alio WEAR Study: Long-term Wear of the Alio Platform

Not Applicable
Recruiting
Conditions
End Stage Kidney Disease
First Posted Date
2023-09-28
Last Posted Date
2023-10-11
Lead Sponsor
Alio, Inc.
Target Recruit Count
250
Registration Number
NCT06056739
Locations
🇺🇸

Site 1, Huntley, Illinois, United States

The Jordan Study for End-Stage Renal Disease Subjects

Not Applicable
Recruiting
Conditions
End Stage Renal Disease
First Posted Date
2022-05-19
Last Posted Date
2024-06-21
Lead Sponsor
Alio, Inc.
Target Recruit Count
75
Registration Number
NCT05382663
Locations
🇯🇴

Jordan Center for Pharmaceutical Research, Amman, Jordan

The ReModel IHC Study for ESRD Patients

Not Applicable
Completed
Conditions
Dialysis Access Malfunction
First Posted Date
2021-09-09
Last Posted Date
2023-09-22
Lead Sponsor
Alio, Inc.
Target Recruit Count
12
Registration Number
NCT05039541
Locations
🇺🇸

Intermountain Dialysis, Murray, Utah, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath